SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

24 Jun 2015 09:26

RNS Number : 0727R
Consort Medical PLC
24 June 2015
 



 

 

24 June 2015

 

 

Consort Medical plc

 

Notification of Transactions of Directors or

Persons Discharging Managerial Responsibility and Connected Persons

 

DTR 3.1.4

 

 

On 19 June 2015 pursuant to the rules of the Consort Medical plc Deferred Bonus Plan the following Directors/persons discharging managerial responsibilities ("PDMRs") of Consort Medical plc (the "Company"), were granted awards over ordinary shares at a share price of £9.257 ("Shares") in the Company in respect of the financial year 2014/15 as detailed against their name below:

 

 

Deferred Bonus Share Award

 

Director/PDMR

Number of Shares

Jon Glenn

22,581

Richard Cotton

10,272

Lisa King

5,133

Keyvan Djamarani

5,387

Ian Muir

1,350

 

The award was granted as a nil cost option.

 

 

 

 

Enquiries: I Ward 01442 867920

Consort Medical plc is an international medical devices company, focused on developing and manufacturing disposable medical devices for drug delivery. The principal business of the Company is the management of Bespak, a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, and injectables products, and the manufacture of devices for the point of care diagnostics market.

The Group has facilities in King's Lynn, Cambridge, Nelson, Milton Keynes and Hemel Hempstead in the UK. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). The Group's website address is www.consortmedical.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSVZLBLEQFLBBQ

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS